ATRenew Inc. Sponsored ADR RERE
3.94
0.01
0.25%
as of 25 Sep
- Market cap
- $517.7M
- P/E
- 13.6×
Follow RERE
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
28.75 | 26.50 | 18.76 | 13.34 |
P/S ratio |
0.41 | 0.43 | 0.35 | 0.26 | |
P/FCF ratio |
21.66 | 8.95 | 7.90 | 6.53 | |
P/Operating CF |
12.64 | (21.62) | (19.08) | (15.78) | |
P/B ratio |
2.20 | 2.25 | 1.98 | 1.64 | |
Price to Tangible BV |
2.21 | 2.25 | 1.99 | 1.64 | |
EV/Sales |
0.31 | 0.36 | 0.30 | 0.21 | |
EV/EBITDA |
17.69 | 16.43 | 12.10 | 7.76 | |
EV/Operating CF |
9.17 | 5.61 | 5.20 | 3.89 | |
EV/FCF |
16.15 | 7.49 | 6.94 | 5.19 | |
Quick Ratio |
2.09 | 1.44 | 1.19 | 1.23 | |
Current Ratio |
3.30 | 2.49 | 2.42 | 2.36 | |
Net Debt/EBITDA |
(16.82) | (8.30) | (5.21) | (7.42) | |
Debt/Assets |
2.83% | 5.41% | 4.92% | 7.23% | |
Debt/Equity |
0.04 | 0.08 | 0.07 | 0.11 | |
Asset Turnover |
3.71 | 3.88 | 4.06 | 4.28 | |
Operating CF/Net income |
0.00 | (3.07) | 0.00 | 0.00 | |
Capex/Depreciation |
— | (1.19) | — | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.51% | 8.46% | 9.31% | 9.13% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.80% | 0.00% | 0.00% | |
Graham Net Nets |
0.38 | 0.31 | 0.35 | 0.45 | |
Graham Number |
0.00 | 3.26 | 0.00 | 0.00 | |
Earnings Yield |
3.48% | 3.77% | 5.33% | 7.49% | |
Free Cash Flow Yield |
4.62% | 11.17% | 12.65% | 15.31% | |
Revenue per Share |
2.99 | 3.92 | 3.70 | 4.03 | |
Operating CF per Share |
0.00 | (0.25) | 0.00 | 0.00 | |
Capex per Share |
0.00 | (0.08) | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | (0.33) | 0.00 | 0.00 | |
Cash per Share |
1.27 | 1.07 | 0.76 | 1.08 | |
Shareholders Equity per Share |
2.26 | 2.36 | 2.37 | 2.48 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.26 | 2.36 | 2.37 | 2.48 | |
Free Cash Flow |
— | (79.09) | — | — | |
Working Capital |
428.99 | 405.85 | 405.90 | 432.27 | |
Capital Expenditures |
— | (19.81) | — | — | |
Net Current Asset Value |
417.83 | 395.50 | 396.17 | 420.36 | |
EV/EBIT |
17.69 | 16.43 | 12.10 | 7.76 | |
Capex to Sales |
0.00 | 0.02 | 0.00 | 0.00 | |
Net Profit Margin |
1.76% | 2.04% | 2.19% | 1.95% | |
Price to Operating Income |
23.73 | 19.65 | 13.78 | 9.78 | |
| Other line items | |||||
Average Receivables |
74.94 | 90.32 | 116.38 | 115.24 | |
Average Payables |
17.78 | 35.73 | 26.82 | 25.10 | |
Average Inventory |
97.39 | 113.45 | 158.45 | 164.95 | |
Average Assets |
726.13 | 775.27 | 802.85 | 827.52 | |
Average Common Equity |
— | 563.81 | — | — |
Columns are period end dates